BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3439658)

  • 41. Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone.
    Hildebrand BA; Arroyo R
    J Clin Rheumatol; 2010 Apr; 16(3):143-5. PubMed ID: 20216327
    [No Abstract]   [Full Text] [Related]  

  • 42. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
    Baron M; Small P
    J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK; Yang YH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective study of polymyositis in Auckland over 10 years.
    Ogle S
    N Z Med J; 1980 Dec; 92(673):433-5. PubMed ID: 6937784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS; Costner MI
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using "real clinic" definitions to predict the course of juvenile dermatomyositis: comment on the article by Stringer et al.
    Charuvanij S; Tucker LB
    Arthritis Rheum; 2009 Aug; 60(8):2545-6; author reply 2546. PubMed ID: 19644883
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjunctive use of hydroxychloroquine in childhood dermatomyositis.
    Olson NY; Lindsley CB
    J Rheumatol; 1989 Dec; 16(12):1545-7. PubMed ID: 2483176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Juvenile dermatomyositis.
    Hill RH; Wood WS
    Can Med Assoc J; 1970 Nov; 103(11):1152-6. PubMed ID: 4321324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of polymyositis and dermatomyositis.
    Ansell BM
    Clin Rheum Dis; 1984 Apr; 10(1):205-13. PubMed ID: 6734117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dermatomyositis and polymyositis].
    Tanimoto K
    Nihon Rinsho; 1993 Jan; 51 Suppl():535-41. PubMed ID: 8459585
    [No Abstract]   [Full Text] [Related]  

  • 57. [Infantile dermatomyositis. Clinical aspects and prospective treatments].
    Cordone G; Buoncompagni A; Ciccone O; Minetti C; Fasce L; Scribanis R; De Langlade E
    Minerva Pediatr; 1991 Oct; 43(10):621-30. PubMed ID: 1758383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of dermatomyositis with methotrexate and prednisone.
    Giannini M; Callen JP
    Arch Dermatol; 1979 Oct; 115(10):1251-2. PubMed ID: 507874
    [No Abstract]   [Full Text] [Related]  

  • 59. Inverse Gottron's papules: an unusual cutaneous manifestation of juvenile dermatomyositis.
    Quinter SD; Chiu YE; Lyon VB; Holland KE; Ruggeri SY; Drolet BA
    Pediatr Dermatol; 2012; 29(5):641-4. PubMed ID: 22211376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognosis and current treatment of dermatomyositis].
    Sánchez Yus E
    Med Cutan Ibero Lat Am; 1977; 5(5):367-72. PubMed ID: 368460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.